| Literature DB >> 33223663 |
Manna S Jacob1, Karthik Gunasekaran1, Angel T Miraclin2, Mohammad Sadiq1, C Vignesh Kumar1, Ajoy Oommen1, Maria Koshy1, Ajay Kumar Mishra1, Ramya Iyadurai1.
Abstract
BACKGROUND: Cerebral venous thrombosis (CVT) secondary to infectious aetiology has become rare in the antibiotic era, but is still encountered in clinical practice occasionally. In this study, we describe the clinical profile, diagnosis, and management of patients with CVT secondary to an infectious aetiology.Entities:
Keywords: Bacterial infection; cerebral venous thrombosis; meningitis; outcome
Year: 2020 PMID: 33223663 PMCID: PMC7657302 DOI: 10.4103/aian.AIAN_341_20
Source DB: PubMed Journal: Ann Indian Acad Neurol ISSN: 0972-2327 Impact factor: 1.383
Figure 1Strobe figure
Baseline characteristics of patients with CVT secondary to bacterial infection (n-22)
| Variable | Value, |
|---|---|
| Age (mean±SD), years | 43.05±17.71 |
| Sex (Male/Female) | 17/5 |
| Co morbidities | |
| Diabetes Mellitus | 6 (27.3) |
| Hypertension | 3 (13.6) |
| Presenting complaints | |
| Fever | 17 (77.3) |
| Headache | 16 (72.7) |
| Depressed sensorium | 14 (63.6) |
| Vomiting | 11 (50) |
| Focal deficits | 9 (40.9) |
| Seizures | 5 (22.7) |
| Focus of infection | |
| Pyogenic meningitis | 12 (54.5) |
| Chronic suppurative otitis media | 4 (18.2) |
| Malignant otitis externa | 1 (4.5) |
| Orbital Cellulitis | 4 (18.2) |
| Bacteremia | 1 (4.5) |
| CSF analysis ( | |
| CSF WBC counts, median (IQR), cells/cumm | 115 (40-2300) |
| CSF Neutrophil count, median (IQR), cells/cumm | 85 (23-96) |
| CSF Lymphocyte count, median (IQR), cells/cumm | 11 (4-76) |
| CSF Protein, median (IQR), mg % | 98 (66-430) |
| CSF Glucose, median (IQR) mg % | 59 (10.0-71.0) |
| Duration of antibiotic, mean (SD) days | 18.9 (10.2) |
| Duration of hospitalisation, mean (SD) days | 13.1 (8.1) |
CSF-cerebrospinal fluid, WBC- White blood cells, IQR- Interquartile range
Aetiological agents of patients with CVT secondary to bacterial infection (n-22)
| Pyogenic CVT with meningitis (CSF Culture) | Pyogenic CVT with parameningeal focus | ||
|---|---|---|---|
| Streptococcus pneumoniae | 2 | MSSA | 3 |
| Klebsiella pneumoniae | 1 | MRSA | 2 |
| Streptococcus suis | 1 | Pseudomonas aerugniosa | 1 |
| Culture negative | 7 | Proteus mirabilis | 1 |
| Culture negative | 3 | ||
CVT-cerebral venous thrombosis, CSF- Cerebrospinal fluid, MSSA-Methicillin sensitive staphylococcus aureus, MRSA- Methicillin resistant staphylococcus aureus
Figure 2Contrast enhanced CT brain and MRI images, (a)- shows filling defect in the left transverse sinus, (b) - shows leptomeningeal enhancement and (c) - shows filling defect in the straight sinus, (d) - post contrast MRI showing filling defect in the posterior third of superior sagittal sinus, (e) - post contrast MRI imaging shows thrombosis of the deep venous system, (f) - T2 Flair image showing bilateral thalamic hyperintensity suggestive of deep venous CVT
Sinus involved in patient with CVT secondary to bacterial infections (n-22)
| Pyogenic Meningitis | CSOM/MOE | Orbital Cellulitis | Bacteremia | |
|---|---|---|---|---|
| Transverse Sinus | 11 | 3 | 0 | 0 |
| Sigmoid Sinus | 7 | 4 | 0 | 0 |
| Cavernous Sinus | 2 | 1 | 4 | 0 |
| Superior Sagittal Sinus | 5 | 0 | 0 | 1 |
CSOM- Chronic suppurative otitis media, MOE-Middle ear infection